Novartis India share price jumps 10% | What lies ahead for the stock?
2026-10-05 10:52:08Novartis India share price jumps 10% | What lies ahead for the stock? Livemint...
Read MoreNovartis India shares soar 18% to record high; extend 9-day gains to 74%; here\'s why
2026-09-10 12:50:35Novartis India shares soar 18% to record high; extend 9-day gains to 74%; here\'s why Business Today...
Read MoreNovartis India zooms 51% in 3 days; what\'s driving the pharma stock?
2026-09-10 10:56:54Novartis India zooms 51% in 3 days; what\'s driving the pharma stock? Business StandardNovartis-Pfizer trademark deal has opposite impact on their stock prices; Novartis India jumps 20% while Pfizer slips 3% BusinessLineNovartis India to acquire Pfizer hypertension brand Minipress for 1250 crore pharma.economictimes.indiatimes.comUpper Circuit: Novartis India shares gain for eighth straight day to a record high cnbctv18.comNovartis India to Acquire Minipress, Minipres Trademarks From Pfizer for Rs 1,250 Crore Medical DialoguesNovartis India shares surge 13%, hit fresh 52-week high on entering ophthalmology therapy UpstoxNovartis India acquires Pfizer brands for $132m Yahoo FinanceMinipress changes hands: Novartis India buys Pfizer brands for Rs 1,250 crore Moneycontrol.comNovartis India Ltd to acquire BP drug trademarks from Pfizer Inc, for 1,250 crore BusinessLine<b...
Read MoreNovartis-Pfizer trademark deal has opposite impact on their stock prices; Novartis India jumps 20% while Pfizer slips 3%
2026-09-09 21:28:43Novartis-Pfizer trademark deal has opposite impact on their stock prices; Novartis India jumps 20% while Pfizer slips 3% BusinessLine...
Read MoreNovartis India Ltd leads gainers in \'B\' group
2026-09-09 12:56:03Novartis India Ltd leads gainers in \'B\' group Business Standard...
Read MoreNovartis India shares zoom 20% to hit record high; Minipress deal fuels rally
2026-09-09 11:28:26Novartis India shares zoom 20% to hit record high; Minipress deal fuels rally Business Today...
Read MoreNovartis faces third clinical-trial setback in a week as muscle drug fails
2026-09-08 13:18:28Novartis faces third clinical-trial setback in a week as muscle drug fails Business Standard...
Read MoreAnnouncement under Regulation 30 (LODR)-Credit Rating
07-Oct-2026 | Source : BSEIntimation of the Credit Ratings assigned by CARE Ratings Limited.
Board Meeting Intimation for Consideration Of Raising Of Funds Through The Issuance Of Equity Shares Of The Company.
05-Oct-2026 | Source : BSENovartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/10/2026 inter alia to consider and approve the raising of funds through the issuance of equity shares of our Company with a face value of ? 5 each (Equity Shares) by way of a rights issue to its eligible equity shareholders (Rights Issue).
Announcement under Regulation 30 (LODR)-Change of Company Name
01-Oct-2026 | Source : BSEIntimation of the Change of Name of Company from Novartis India Limited to Evonile Pharma Limited pursuant to the Fresh Certificate of Incorporation dated October 01 2026 issued by Ministry of Corporate Affairs.
Corporate Actions
03 Nov 2026
Novartis India Ltd has declared 500% dividend, ex-date: 23 Jul 25
No Splits history available
No Bonus history available
No Rights history available